Diagnostic, Prognostic and Predictive Biomarkers and New Targets for Treatment in Gastric Cancer
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 2907
Special Issue Editor
Interests: gastric cancer; immunotherapy; targeted therapy; systemic treatment; clinical trial
Special Issue Information
Dear Colleagues,
In 2020, gastric cancer (GC) was responsible for more than one million new cancer diagnoses and approximately 769,000 deaths. It is the fifth most common cancer and the fourth leading cause of death worldwide. In the diagnosis of GC, endoscopy and imaging study have an important role. And, in treatment, endoscopic approaches, surgery, systemic treatment and radiotherapy are mainly used. Due to advances in the diagnosis and treatment of this disease, the outcome for early gastric cancer has improved, but there is still a risk of recurrence. Moreover, prognosis is still poor in advanced gastric cancer. Accordingly, many studies on biomarkers for diagnosis, treatment and prognosis are needed. This Special Issue will provide insights regarding the diagnostic, prognostic and predictive biomarkers of GC. Authors are invited to submit their original research and review articles to Biomedicines.
Potential topics include but are not limited to:
- Molecular biomarkers;
- Imaging biomarkers;
- Treatment biomarkers;
- Radiotherapy;
- Chemotherapy;
- Immunotherapy;
- Targeted therapy;
- Systemic treatment.
Dr. In-Ho Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- treatment
- biomarker
- translational research